Effect of chymotrypsin C and related proteins on pancreatic cancer cell migration

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 5, 2011, Pages 362-371

  Wang, Haibo ^a   Sha, Wei ^a   Liu, Zhixue ^b   Chi, Cheng Wu ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

cell migration; chymotrypsin C; cytokeratin 18; proteomics; two dimensional fluorescence differential in gel electrophoresis (2D DIGE)

Indexed keywords

CHYMOTRYPSIN; CHYMOTRYPSIN C; PRIMER DNA;

ARTICLE; HUMAN; METASTASIS; NUCLEOTIDE SEQUENCE; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BASE SEQUENCE; CHYMOTRYPSIN; DNA PRIMERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 79955373911     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr022     Document Type: Article

References (36)

1. Iio-Akama K, Sasamoto H, Miyazawa K, Miura S and Tobita T. Active forms of chymotrypsin C isolated from autolyzed porcine pancreas glands. Biochim Biophys Acta 1985, 831: 249-256. (Pubitemid 15242683)
2. Keil-Dlouha V, Puigserver A, Marie A and Keil B. On subunit II of bovine procarboxypeptidase A. Enzymatic specificity after tryptic activation. Biochim Biophys Acta 1972, 276: 531-535.
3. Folk JE and Cole PW. Chymotrypsin C. II. Enzymatic specificity toward several polypeptides. J Biol Chem 1965, 240: 193-197.
4. Szmola R and Sahin-Tóth M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y. Proc Natl Acad Sci USA 2007, 104: 11227-11232. (Pubitemid 47175123)
5. Tomomura A, Tomomura M, Fukushige T, Akiyama M, Kubota N, Kumaki K and Nishii Y, et al. Molecular cloning and expression of serum calcium-decreasing factor (caldecrin). J Biol Chem 1995, 270: 30315-30321. (Pubitemid 26006311)
6. Rosendahl J, Witt H, Szmola R, Bhatia E, Ó zsvári B, Landt O and Schulz HU, et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008, 40: 79-82.
7. Anthony K. Harvard Medical School Family Health Guide. New York: Simon and Schuster Press, 1999.
8. Wan XY and Liu JY. Comparative proteomics analysis reveals an intimate protein network provoked by hydrogen peroxide stress in rice seedling leaves. Mol Cell Proteomics 2008, 7: 1469-1488.
9. Tomas A, Futter C and Moss SE. Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis. J Cell Biol 2004, 165: 813-822. (Pubitemid 38821972)
10. Kumble KD, Hirota M, Pour PM and Vishwanatha JK. Enhanced levels of annexins in pancreatic carcinoma cells of syrian hamsters and their intrapancreatic allografts. Cancer Res 1992, 52: 163-167.
11. Song J, Shih Ie M, Chan DW and Zhang Z. Suppression of annexin A11 in ovarian cancer: implications in chemoresistance. Neoplasia 2009, 11: 605-614.
12. Van Sprundel RG, Van Den Ingh TS, Desmet VJ, Katoonizadeh A, Penning LC, Rothuizen J and Roskams T, et al. Keratin 19 marks poor differentiation and a more aggressive behavior in canine and human hepatocellular tumors. Comp Hepatol 2010, 9: 4.
13. Chang CC, Yang SH, Chien CC, Chen SH, Pan S, Lee CL and Lin CM. Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy. BMC Cancer 2009, 9: 376.
14. Suo J, Wang Q, Jin HJ, Li H and Zhao H. K-19 mRNA RT-PCR in detecting micrometastasis in regional lymph nodes of gastric cancer. World J Gastroenterol 2006, 12: 5219-5222. (Pubitemid 44355922)
15. Jung YS, Lee KJ, Kim HJ, Yim HE, Park JS, Soh EY and Kim MW, et al. Clinical significance of bone marrow micrometastasis detected by nested RT-PCR for keratin-19 in breast cancer patients. Jpn J Clin Oncol 2003, 33: 167-172. (Pubitemid 43102859)
16. Hoffmann K, Kerner C, Wilfert W, Mueller M, Thiery J, Hauss J and Witzigmann H. Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients. World J Gastroenterol 2007, 13: 257-263. (Pubitemid 46231329)
17. Scaffidi P and Misteli T. Good news in the nuclear envelope: loss of lamin A might be a gain. J Clin Invest 2006, 116: 632-634. (Pubitemid 43326870)
18. Venables RS, McLean S, Luny D, Moteleb E, Morley S, Quinlan RA and Lane EB, et al. Expression of individual lamins in basal cell carcinomas of the skin. Br J Cancer 2001, 84: 512-519. (Pubitemid 32215879)
19. Lu QY, Yang Y, Jin YS, Zhang ZF, Heber D, Li FP and Dubinett SM, et al.. Effects of green tea extract on lung cancer A549 cells: proteomic identification of proteins associated with cell migration. Proteomics 2009, 9: 757-767.
20. Wu Z, Wu L, Weng D, Xu D, Geng J and Zhao F. Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma. J Exp Clin Cancer Res 2009, 28: 8.
21. Lovat PE, Corazzari M, Armstrong JL, Martin S, Pagliarini V, Hill D and Brown AM, et al. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res 2008, 68: 5363-5369.
22. Wang MH, Grossmann ME and Young CY. Forced expression of heatshock protein 70 increases the secretion of Hsp70 and provides protection against tumor growth. Br J Cancer 2004, 90: 926-931. (Pubitemid 38406608)
23. Dangles-Marie V, Richon S, El-Behi M, Echchakir H, Dorothée G, Thiery J and Validire P, et al. A three-dimensional tumor cell defect in activating autologous CTLs is associated with inefficient antigen presentation correlated with heat shock protein-70 down-regulation. Cancer Res 2003, 63: 3682-3687. (Pubitemid 36793052)
24. Kulesh DA and Oshima RG. Cloning of the human keratin 18 gene and its expression in nonepithelial mouse cells. Mol Cell Biol 1988, 8: 1540-1550.
25. Trask DK, Band V, Zajchowski DA, Yaswen P, Suh T and Sager R. Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc Natl Acad Sci 1990, 87: 2319-2323.
26. Debus E, Moll R, Franke WW, Weber K and Osborn M. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol 1984, 114: 121-130. (Pubitemid 14183194)
27. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, Wu R and Wu CW. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 1997, 17: 353-360. (Pubitemid 127500840)
28. Dive C, Smith RA, Garner E, Ward T, George-Smith SS, Campbell F and Greenhalf W, et al. Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. Br J Cancer 2010, 102: 577-582.
29. Schaafsma HE, Ramaekers FC, van Muijen GN, Lane EB, Leigh IM, Robben H and Huijsmans A, et al. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. Am J Pathol 1990, 136: 329-343. (Pubitemid 20074608)
30. Oshima RG, Abrams L and Kulesh D. Activation of an intron enhancer within the keratin 18 gene by expression of c-fos and c-jun in undifferentiated F9 embryonal carcinoma cells. Genes Dev 1990, 4: 835-848.
31. Pankov R, Umezawa A, Maki R, Der CJ, Hauser CA and Oshima RG. Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway. Proc Natl Acad Sci USA 1994, 91: 873-877. (Pubitemid 24048469)
32. Takahashi T, Moyer MP, Cano M, Wang QJ, Mountjoy CP, Sanger W and Adrian TE, et al. Differences in molecular biological, biological and growth characteristics between the immortal and malignant hamster pancreatic ductal cells. Carcinogenesis 1995, 16: 931-939.
33. Koelink PJ, Lamers CB, Hommes DW and Verspaget HW. Circulating cell death products predict clinical outcome of colorectal cancer patients. BMC Cancer 2009, 9: 88.
34. Scott LC, Evans TR, Cassidy J, Harden S, Paul J, Ullah R and O'Brien V, et al. Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumor response. Br J Cancer 2009, 101: 410-417.
35. Messai Y, Noman MZ, Derouiche A, Kourda N, Akalay I, Hasmim M and Stasik I, et al. Cytokeratin 18 expression pattern correlates with renal cell carcinoma progression: relationship with Snail. Int J Oncol 2010, 36: 1145-1154.
36. Stigbrand T. The versatility of cytokeratins as tumor markers. Tumor Biol 2001, 22: 1-3.